Pattern to Attend Fortune Brainstorm AI 2024 Conference
November 22, 2024 08:30 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that the Company’s Chair and CEO Mark Anderson will be attending the Fortune...
Pattern Announces Company Presentation at BIO-Europe 2024
October 14, 2024 16:56 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced the Company has been invited to present at the BIO- Europe® 2024 conference....
Pattern’s ProSpectral™ Passes EMC Certifications Required for Commercial Sales
September 24, 2024 08:30 ET
|
PATTERN COMPUTER, INC.
• Company meets all testing required to meet global EMC standards • Broadens ProSpectral™ multi-disease diagnostics research platform to serve diverse growth markets REDMOND, Wash., Sept. 24,...
Pattern and the Medical College of Wisconsin Launch New Pilot Study to Assess Detection of Head, Neck and Lung Cancers Through ProSpectral™ Saliva Analysis
August 21, 2024 15:14 ET
|
PATTERN COMPUTER, INC.
Research collaboration leverages Pattern’s ProSpectral™ multi-disease hyperspectral diagnostics research platformPotentially ushers in a new era of early detection cancer screening REDMOND, Wash.,...
Pattern Announces Company Presentation at LSX World Congress USA
August 07, 2024 09:00 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced the Company will be presenting at the LSX World Congress USA, which will be...
Pattern CEO Joins Nobelists and Global Leaders Looking Toward the Next Decade in the International Release of 'IGNITE.2034'
August 06, 2024 09:00 ET
|
PATTERN COMPUTER, INC.
Mark Anderson, Chair and CEO, joins renowned authors in contributing chapter entitled “The Future of AI: Pattern Discovery, Explainable AI, and Ethical AI” REDMOND, Wash., Aug. 06, 2024 (GLOBE...
Pattern’s Ovarian Cancer Combination Candidate Shows Promising In Vivo Results
July 30, 2024 17:13 ET
|
PATTERN COMPUTER, INC.
Targets high-grade serous ovarian cancer, the most common and deadliest form of gynecologic cancerUnderscores potential of Pattern Discovery Engine™ to uncover novel therapeutic combinations for...
Pattern Computer ProSpectral™ Device Found to be “Potentially Disruptive” in Clinical Diagnostics and Military Bio Attack Roles
June 17, 2024 17:39 ET
|
PATTERN COMPUTER, INC.
• New paper on sensing research collaboration with national labs available on medRxiv • Hyperspectral sensing shown to enable agnostic reagent-free diagnostics • Study addresses clear and critical...
Pattern Announces Filing of Provisional Patent Applications for Treatment of Metastatic Castration-Resistant Prostate Cancer
June 12, 2024 14:25 ET
|
PATTERN COMPUTER, INC.
Continued expansion of Pattern’s IP portfolioSignificant progress in expanding industry-leading oncology pipeline REDMOND, Wash., June 12, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc....
Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
May 22, 2024 08:30 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., May 22, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) proudly announces the initiation of synergy and efficacy testing for two promising drug...